Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;101(6):1289-1290.
doi: 10.1016/j.kint.2022.04.006. Epub 2022 Apr 12.

Humoral response after a fourth "booster" dose of a Coronavirus disease 2019 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patients

Pierre Housset  1 , Sabah Kubab  2 , Latifa Hanafi  3 , Agathe Pardon  3 , Nathalie Vittoz  3 , Dogan-Firat Bozman  3 , Valérie Caudwell  3 , Anne-Laure Faucon  4
Affiliations

Humoral response after a fourth "booster" dose of a Coronavirus disease 2019 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patients

Pierre Housset et al. Kidney Int. 2022 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kinetics of antispike antibodies. The figure shows the antispike antibody (Ab) levels before, and 1 (M1), 3 (M3), and 6 (M6) months after the third dose of the mRNA BNT162b2 vaccine, and after the fourth vaccine dose (BNT162b2 Pfizer–BioNech or mRNA-1273 Moderna) in dialysis patients. Each point represents individual data. Antibody titers lower than 1 cannot be plotted in the graph because of the logarithm scale. The red points and vertical lines indicate the median with interquartile range. Conversion factor: 1 AU/ml = 1.0288 BAU/ml.
See this image and copyright information in PMC

References

    1. Bensouna I., Caudwell V., Kubab S., et al. SARS-CoV-2 antibody response after a third dose of the BNT162b2 vaccine in patients receiving maintenance hemodialysis or peritoneal dialysis. Am J Kidney Dis. 2022;79:185–192.e1. - PMC - PubMed
    1. Housset P., Kubab S., Pardon A., et al. Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients. J Nephrol. 2022;35:783–785. - PMC - PubMed
    1. Carr E.J., Wu M., Harvey R., et al. Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients. Lancet. 2022;399:800–802. - PMC - PubMed
    1. Muench P., Jochum S., Wenderoth V., et al. Development and validation of the Elecsys anti-SARS-CoV-2 immunoassay as a highly specific tool for determining past exposure to SARS-CoV-2. J Clin Microbiol. 2020;58 e01694-20. - PMC - PubMed